Mutated influenza A virus exhibiting reduced susceptibility to baloxavir marboxil from an experimentally infected horse
{{output}}
Baloxavir marboxil (BXM), an inhibitor of the cap-dependent endonuclease of the influenza virus polymerase acidic protein (PA), exerts an antiviral effect against influenza A virus. It has been available in Japan since March 2018. This study evaluated the anti... ...
